EyePoint Pharmaceuticals Ownership | Who Owns EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals Ownership Summary
EyePoint Pharmaceuticals is owned by 106.17% institutional investors, 3.53% insiders. Cormorant asset management, lp is the largest institutional shareholder, holding 15.29% of EYPT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.01% of its assets in EyePoint Pharmaceuticals shares.
EYPT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | EyePoint Pharmaceuticals | 106.17% | 3.53% | -9.70% |
| Sector | Healthcare Stocks | 279.17% | 10.51% | -189.68% |
| Industry | Biotech Stocks | 63.95% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Cormorant asset management, lp | 8.32M | 15.29% | $62.02M |
| Suvretta capital management | 6.78M | 12.46% | $50.53M |
| Adage capital partners gp | 5.75M | 10.56% | $42.84M |
| Blackrock funding, inc. /de | 5.28M | 9.70% | $39.35M |
| Franklin resources | 4.14M | 7.60% | $30.82M |
| Blackrock | 3.76M | 7.12% | $32.75M |
| Vanguard group | 3.80M | 6.98% | $28.33M |
| Federated hermes | 3.71M | 6.81% | $27.62M |
| Tcg crossover management | 3.57M | 6.56% | $26.61M |
| Ra capital management | 3.18M | 5.84% | $23.70M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Patient square capital lp | 1.41M | 3.93% | $10.51M |
| Cormorant asset management, lp | 8.32M | 3.41% | $62.02M |
| Tcg crossover management | 3.57M | 2.60% | $26.61M |
| Essex woodlands management | 1.17M | 2.01% | $8.72M |
| 5am venture management | 1.05M | 1.87% | $7.82M |
| Suvretta capital management | 6.78M | 1.72% | $50.53M |
| Blue owl capital lp | 667.59K | 1.15% | $4.97M |
| Artia global partners lp | 216.70K | 0.58% | $1.61M |
| Finepoint capital lp | 1.11M | 0.51% | $8.28M |
| Perceptive advisors | 1.54M | 0.32% | $11.45M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 3.18M | 0.32% | 3.18M |
| Tcg crossover management | 3.57M | 2.60% | 2.65M |
| Adage capital partners gp | 5.75M | 0.07% | 1.96M |
| Federated hermes | 3.71M | 0.06% | 1.78M |
| Suvretta capital management | 6.78M | 1.72% | 1.61M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Octagon capital advisors lp | - | - | -1.09M |
| Deerfield management company, l.p. (series c) | - | - | -877.79K |
| Point72 asset management | - | - | -857.85K |
| Fiera capital | - | - | -677.04K |
| First turn management | - | - | -585.45K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 3.18M | 0.32% | 3.18M | $23.70M |
| Blue owl capital lp | 667.59K | 1.15% | 667.59K | $4.97M |
| Nantahala capital management | 600.00K | 0.19% | 600.00K | $4.47M |
| Abrdn | 230.75K | 0.00% | 230.75K | $1.72M |
| Susquehanna fundamental investments | 123.77K | 0.01% | 123.77K | $922.08K |
Sold Out
| Holder | Change |
|---|---|
| Assetmark | -15.00 |
| Continuum advisory | -16.00 |
| Park place capital | -23.00 |
| Russell investments group | -24.00 |
| Principal securities | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 157 | 4.67% | 74,070,140 | -0.48% | 106 | 0.57% | 81 | -16.49% | 46 | 91.67% |
| Dec 31, 2024 | 148 | 2.78% | 74,156,377 | 26.76% | 136 | 1.18% | 95 | 41.79% | 24 | -52.00% |
| Sep 30, 2024 | 143 | -8.92% | 58,500,958 | 0.17% | 107 | 0.88% | 68 | -26.09% | 48 | 9.09% |
| Jun 30, 2024 | 157 | -10.29% | 58,402,790 | 6.20% | 110 | 1.02% | 92 | -21.37% | 44 | 18.92% |
| Mar 31, 2024 | 175 | 12.90% | 54,991,981 | 11.00% | 103 | 0.75% | 117 | 25.81% | 37 | 5.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.07M | 3.01% | 82.42K |
| Federated Hermes Kaufmann Growth | 2.04M | 2.96% | - |
| Federated Hermes Kaufmann R | 2.04M | 2.96% | - |
| Franklin Biotechnology Discv A(acc)USD | 1.86M | 2.71% | 91.00K |
| iShares Russell 2000 ETF | 1.67M | 2.43% | 819.00 |
| Federated Hermes Kaufmann Small Cap Grow | 1.61M | 2.34% | - |
| Federated Hermes Kaufmann Small Cap A | 1.61M | 2.34% | - |
| Vanguard US Total Market Shares ETF | 1.56M | 2.27% | - |
| Franklin US Small Cap Growth Equity | 1.17M | 1.70% | -9.73K |
| Franklin Small Cap Growth Adv | 1.17M | 1.70% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 16, 2025 | Zaderej Karen L. | - | Buy | $29.05K |
| May 19, 2025 | Zaderej Karen L. | - | Buy | $29.95K |
| May 14, 2025 | Zaderej Karen L. | - | Buy | $27.10K |
| May 15, 2025 | Zaderej Karen L. | - | Buy | $27.35K |
| Aug 20, 2024 | DICICCO WENDY F | - | Buy | $20.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | 4 | - |
| 2025 Q1 | - | - |
| 2024 Q3 | 4 | 1 |
| 2024 Q2 | 4 | 2 |
| 2024 Q1 | 2 | 25 |
EYPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools